Stratec SE (SBS) - Total Assets
Based on the latest financial reports, Stratec SE (SBS) holds total assets worth €431.24 Million EUR (≈ $504.16 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See SBS total equity for net asset value and shareholders' equity analysis.
Stratec SE - Total Assets Trend (2002–2024)
This chart illustrates how Stratec SE's total assets have evolved over time, based on quarterly financial data.
Stratec SE - Asset Composition Analysis
Current Asset Composition (December 2024)
Stratec SE's total assets of €431.24 Million consist of 50.2% current assets and 49.8% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 10.6% |
| Accounts Receivable | €43.18 Million | 9.7% |
| Inventory | €117.62 Million | 26.4% |
| Property, Plant & Equipment | €80.25 Million | 18.0% |
| Intangible Assets | €62.89 Million | 14.1% |
| Goodwill | €50.98 Million | 11.5% |
Asset Composition Trend (2002–2024)
This chart illustrates how Stratec SE's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see SBS company net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Stratec SE's current assets represent 50.2% of total assets in 2024, a decrease from 82.1% in 2002.
- Cash Position: Cash and equivalents constituted 10.6% of total assets in 2024, up from 3.8% in 2002.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 25.0% of total assets, an increase from 1.0% in 2002.
- Asset Diversification: The largest asset category is inventory at 26.4% of total assets.
Stratec SE Competitors by Total Assets
Key competitors of Stratec SE based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
INKON Life Technology Co Ltd
SHE:300143
|
China | CN¥4.15 Billion |
|
CareRay Digital Medical Technology Co Ltd
SHG:688607
|
China | CN¥988.48 Million |
|
Senseonics Holdings, Inc. Common Stock
NYSE MKT:SENS
|
USA | $139.92 Million |
|
Universus Photo Imagings Limited
NSE:UNIVPHOTO
|
India | Rs8.57 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
|
Aligned Genetics Inc
KQ:238120
|
Korea | ₩45.11 Billion |
|
Heramed Ltd
AU:HMD
|
Australia | AU$1.04 Million |
|
Acarix A/S
ST:ACARIX
|
Sweden | Skr48.33 Million |
Stratec SE - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.19 | 2.52 | 4.38 |
| Quick Ratio | 1.65 | 0.93 | 2.47 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €158.40 Million | €142.13 Million | €120.61 Million |
Stratec SE - Advanced Valuation Insights
This section examines the relationship between Stratec SE's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.01 |
| Latest Market Cap to Assets Ratio | 0.54 |
| Asset Growth Rate (YoY) | -4.6% |
| Total Assets | €445.06 Million |
| Market Capitalization | $242.15 Million USD |
Valuation Analysis
Below Book Valuation: The market values Stratec SE's assets below their book value (0.54x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Stratec SE's assets decreased by 4.6% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Stratec SE (2002–2024)
The table below shows the annual total assets of Stratec SE from 2002 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | €445.06 Million ≈ $520.32 Million |
-4.61% |
| 2023-12-31 | €466.58 Million ≈ $545.48 Million |
+17.38% |
| 2022-12-31 | €397.50 Million ≈ $464.72 Million |
+7.86% |
| 2021-12-31 | €368.52 Million ≈ $430.84 Million |
+11.03% |
| 2020-12-31 | €331.90 Million ≈ $388.03 Million |
+10.85% |
| 2019-12-31 | €299.41 Million ≈ $350.05 Million |
+8.77% |
| 2018-12-31 | €275.29 Million ≈ $321.84 Million |
+4.36% |
| 2017-12-31 | €263.78 Million ≈ $308.38 Million |
+2.25% |
| 2016-12-31 | €257.97 Million ≈ $301.59 Million |
+62.31% |
| 2015-12-31 | €158.94 Million ≈ $185.82 Million |
+15.38% |
| 2014-12-31 | €137.75 Million ≈ $161.04 Million |
+16.95% |
| 2013-12-31 | €117.79 Million ≈ $137.71 Million |
-3.32% |
| 2012-12-31 | €121.84 Million ≈ $142.44 Million |
+9.77% |
| 2011-12-31 | €111.00 Million ≈ $129.77 Million |
+12.30% |
| 2010-12-31 | €98.84 Million ≈ $115.55 Million |
+15.21% |
| 2009-12-31 | €85.79 Million ≈ $100.29 Million |
+22.61% |
| 2008-12-31 | €69.97 Million ≈ $81.80 Million |
+4.63% |
| 2007-12-31 | €66.87 Million ≈ $78.18 Million |
+17.07% |
| 2006-12-31 | €57.12 Million ≈ $66.78 Million |
+30.93% |
| 2005-12-31 | €43.63 Million ≈ $51.01 Million |
+70.18% |
| 2004-12-31 | €25.64 Million ≈ $29.97 Million |
+7.89% |
| 2003-12-31 | €23.76 Million ≈ $27.78 Million |
+110854.07% |
| 2002-12-31 | €21.41K ≈ $25.04K |
-- |
About Stratec SE
Stratec SE, together with its subsidiaries, provides automation solutions for in-vitro diagnostics and life science companies in Germany, the European Union, and internationally. The company designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers. It also provides consumables for diagnostics and medical applications; and integrating instrumentation… Read more